Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Holdings Increased by AIA Group Ltd

AIA Group Ltd boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 18,533 shares of the medical equipment provider’s stock after acquiring an additional 722 shares during the period. AIA Group Ltd’s holdings in Intuitive Surgical were worth $9,673,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Atala Financial Inc acquired a new stake in Intuitive Surgical during the fourth quarter valued at $25,000. Berbice Capital Management LLC acquired a new position in Intuitive Surgical in the fourth quarter worth approximately $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the 4th quarter worth $28,000. Summit Securities Group LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $30,000. Finally, Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth about $31,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 3.2 %

Shares of NASDAQ:ISRG opened at $491.84 on Monday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The firm has a market cap of $175.18 billion, a P/E ratio of 76.73, a P/E/G ratio of 5.85 and a beta of 1.43. The company’s 50-day moving average price is $556.28 and its two-hundred day moving average price is $532.97.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 over the last three months. 0.70% of the stock is owned by insiders.

Analyst Ratings Changes

ISRG has been the topic of a number of research analyst reports. Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. UBS Group upped their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Raymond James raised their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Citigroup upped their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Finally, Truist Financial lowered their price target on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research note on Monday, March 17th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.